Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.

Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ
Int J Radiat Oncol Biol Phys. 2010 77 (2): 468-76

PMID: 19577867 · DOI:10.1016/j.ijrobp.2009.05.018

MeSH Terms (20)

Age Factors Antineoplastic Combined Chemotherapy Protocols Bridged-Ring Compounds Carboplatin Combined Modality Therapy Dose Fractionation, Radiation Female Head and Neck Neoplasms Humans Hypothyroidism Male Middle Aged Paclitaxel Radiation Injuries Radiography Radiotherapy, Intensity-Modulated Retrospective Studies Risk Factors Taxoids Thyroid Gland

Connections (4)

This publication is referenced by other Labnodes entities: